Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis.
Aliya BryceSara DavisonBart J CurrieJohanna M BirrellRobert W BairdAsanga AbeyaratneSandawana William MajoniTeana Brewster-O'BrienSteven Y C TongPublished in: Open forum infectious diseases (2024)
Hemodialysis is a risk factor for Staphylococcus aureus bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required.